Cardiometabolic and genetic factors in the progression of metabolic dysfunction-associated steatotic liver disease

Aim. To evaluate the contribution of cardiometabolicfactors and PNPLA3 I148M (rs738409 CG) gene polymorphism to the development of compensated advanced chronic liver disease (cACLD) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). Materials and methods. 108 patie...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Veronika P. Gomonova, Karina L. Raikhelson
פורמט:	Artigo
שפה:	Russo
יצא לאור:	"Consilium Medicum" Publishing house 2025-01-01
סדרה:	Терапевтический архив
נושאים:	metabolic dysfunction-associated steatotic liver disease compensated advanced chronic liver disease cardiometabolic risk factors pnpla3 transient elastography
גישה מקוונת:	https://ter-arkhiv.ru/0040-3660/article/viewFile/646288/193078
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!